Eiko Lifesciences Ltd. - Research Center
540204 EIKO Group (XT) BSE data
Results
Statement
More
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Mar ' 19 |
Equity share capital
Share application money
Preference share capital
Reserves & surplus
21.11 |
20.31 |
2.37 |
1.66 |
1.61 |
Secured loans
Unsecured loans
Total
29.42 |
33.18 |
14.28 |
5.68 |
5.69 |
Gross block
15.34 |
15.12 |
0.52 |
0.52 |
0.52 |
Less : revaluation reserve
Less : accumulated depreciation
Net block
13.88 |
14.29 |
0.25 |
0.31 |
0.37 |
Capital work-in-progress
Investments
Current assets, loans & advances
17.11 |
20.40 |
16.15 |
4.95 |
3.27 |
Less : current liabilities & provisions
Total net current assets
15.49 |
18.69 |
13.82 |
4.87 |
3.19 |
Miscellaneous expenses not written
Total
29.42 |
33.18 |
14.28 |
5.68 |
5.69 |
Book value of unquoted investments
Market value of quoted investments
Contingent liabilities
Number of equity sharesoutstanding (Lacs)
83.16 |
83.16 |
38.20 |
38.20 |
38.20 |